Cargando…
Cells to the Rescue: Emerging Cell-Based Treatment Approaches for NMOSD and MOGAD
Cell-based therapies are gaining momentum as promising treatments for rare neurological autoimmune diseases, including neuromyelitis optica spectrum disorders and myelin oligodendrocyte glycoprotein antibody-associated disease. The development of targeted cell therapies is hampered by the lack of ad...
Autores principales: | Derdelinckx, Judith, Reynders, Tatjana, Wens, Inez, Cools, Nathalie, Willekens, Barbara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8347572/ https://www.ncbi.nlm.nih.gov/pubmed/34360690 http://dx.doi.org/10.3390/ijms22157925 |
Ejemplares similares
-
Made to Measure: Patient-Tailored Treatment of Multiple Sclerosis Using Cell-Based Therapies
por: Wens, Inez, et al.
Publicado: (2021) -
NMOSD and MOGAD Dual Positivity: An Extremely Rare Phenomenon
por: Agarwal, Ayush, et al.
Publicado: (2022) -
Targeting B cells to modify MS, NMOSD, and MOGAD: Part 2
por: Graf, Jonas, et al.
Publicado: (2020) -
Targeting B Cells to Modify MS, NMOSD, and MOGAD: Part 1
por: Graf, Jonas, et al.
Publicado: (2020) -
Comparative study of AQP4-NMOSD, MOGAD and seronegative NMOSD: a single-center Belgian cohort
por: Dauby, Solène, et al.
Publicado: (2021)